Picture of BioArctic AB logo

BIOA B BioArctic AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: Eisai Will Request Reconsideration Of Initial Decision For Lecanemab In Australia

Oct 16 (Reuters) - BioArctic AB  BIOAb.ST :
    * EISAI WILL REQUEST RECONSIDERATION OF INITIAL DECISION FOR
LECANEMAB IN AUSTRALIA

Source text for Eikon:  ID:nWkr8cSQvG 
Further company coverage:  BIOAb.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BioArctic AB

See all news